A Prospective, Multicenter, Clinical Trial Designed to Evaluate the Safety and Feasibility of the ELIOS System to Reduce Intraocular Pressure in Patients With Primary Open-Angle Glaucoma as a Standalone Procedure
Status: Recruiting
Location: See all (5) locations...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
Evaluation of the safety and effectiveness of the ELIOS System procedure to reduce intraocular pressure (IOP) in adult subjects with mild to moderate primary open-angle glaucoma (POAG)
Eligibility
Participation Requirements
Sex: All
Minimum Age: 45
Healthy Volunteers: f
View:
• Diagnosis of mild to moderate POAG
• Medicated IOP of \<=24 mmHg
• Shaffer angle grade of III or IV
• CD ratio \<=0.8
• At least 45 years old
Locations
United States
Arizona
Elios Vision Clinical Site
RECRUITING
Glendale
Florida
Elios Vision Clinical Site
RECRUITING
Largo
Illinois
Elios Vision Clinical Site
RECRUITING
Rock Island
Oklahoma
Elios Vision Clinical Site
RECRUITING
Oklahoma City
Wisconsin
Elios Vision Clinical Site
RECRUITING
Kenosha
Contact Information
Primary
Rupali Nangia
rupali@eliosvision.com
714-227-6151
Time Frame
Start Date: 2023-10-18
Estimated Completion Date: 2026-04
Participants
Target number of participants: 65
Treatments
Experimental: ELIOS Procedure
ELIOS Procedure
Related Therapeutic Areas
Sponsors
Leads: Elios Vision, Inc.